A novel mutation in the SDHD gene in a family with inherited paragangliomas - Implications of genetic diagnosis for follow up and treatment

Head and Neck

Volumn 25, Issue 2, 2003, Pages 146-151

  Renard, Laurette ^a   Godfraind, Catherine ^a   Boon, Laurence M ^a,b   Vikkula, Miikka ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

Familial; Genetic; Paraganglioma; Pheochromocytoma; Screening

Indexed keywords

SUCCINATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER SURGERY; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; EXON; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PEDIGREE ANALYSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SDHD GENE;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PARAGANGLIOMA; PEDIGREE; PHEOCHROMOCYTOMA; SEQUENCE ANALYSIS, RNA; SUCCINATE DEHYDROGENASE;

EID: 0037307412     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10220     Document Type: Article

References (28)

1. Kroll AJ, Alexander B, Cochios F, Pechet L. Hereditary deficiencies of clotting factors VII and X associated with carotid-body tumors. N Engl J Med 1964;270:6-13.
2. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-1294.
3. Heutink P, van der Mey AG, Sandkuijl LA, et al. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992;1:7-10.
4. Mariman EC, van Beersum SE, Cremers CW, Struycken PM, Ropers HH. Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 1995;95:56-62.
5. Gimm O, Armanios M, Dziema H, Neumann HP, Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 2000;60:6822-25.
6. Astuti D, Douglas F, Lennard TW, et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001; 357:1181-1182.
7. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54.
8. Westerband A, Hunter GC, Cintora I, et al. Current trends in the detection and management of carotid body tumors. J Vasc Surg 1998;28:84-92; discussion 92-93.
9. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851.
10. Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p2l-22. Am J Hum Genet 1999; 65:125-133.
11. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001;69:1186-1197.
12. Taschner PE, Jansen JC, Baysal BE, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 2001;31:274-281.
13. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26: 268-270.
14. Mariman EC, van Beersum SE, Cremers CW, van Baars FM, Ropers HH. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 1993;91:357-361.
15. Parry DM, Li FP, Strong LC, et al. Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst 1982;68:573-578.
16. Grufferman S, Gillman MW, Pasternak LR, Peterson CL, Young WG, Jr. Familial carotid body tumors: case report and epidemiologic review. Cancer 1980;46:2116-2122.
17. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990;102:382-390.
18. Drovdlic CM, Myers EN, Peters JA, et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001;111:1822-1827.
19. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck 2001; 23:363-371.
20. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997; 60:121-132.
21. Lemaire M, Persu A, Hainaut P, De Plaen JF. Hereditary paraganglioma. J Intern Med 1999;246:113-116.
22. Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001;86: 5210-5216.
23. Farr H. Carotid body tumors: a thirty years experience at Memorial Hospital. Am J Surg 1967;114:614-619.
24. Lenz T, Gossmann J, Schulte KL, Salewski L, Geiger H. Diagnosis of pheochromocytoma. Clin Lab 2002;48:5-18.
25. Myssiorek D, Palestro CJ. 111Indium pentetreotide scan detection of familial paragangliomas. Laryngoscope 1998; 108:228-231.
26. Masuoka J, Brandner S, Paulus W, et al. Germline SDHD mutation in paraganglioma of the spinal cord. Oncogene 2001;20:5084-5086.
27. Milunsky JM, Maher TA, Michels W, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001;100:311-314.
28. Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer 2001;31:255-263.